POLICY RELATING TO SYRINGE EXCHANGE PROGRAMS.

SEC. 1120. POLICY RELATING TO SYRINGE EXCHANGE PROGRAMS. Section 703(a) (21 U.S.C. 1702(a)) is amended by adding at the end the following:“When developing the national drug control policy, any policy of the Director relating to syringe exchange programs for intravenous drug users shall be based on the best available medical and scientific evidence regarding their effectiveness in promoting individual health and preventing the spread of infectious disease, and their impact on drug addiction and use. In making any policy relating to syringe exchange programs, the Director shall consult 120 STAT. 3549 with the National Institutes of Health and the National Academy of Sciences.”.